• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov10
Alterity Therapeutics Presents Favorable Data on ATH434 for Orthostatic Hypotension and MSA
12:26
Oct14
Jason McCarthy Issues Buy Rating on Alterity Therapeutics Stock
18:56
Sep29
Alterity Therapeutics Predicts ATH434 Global Peak Sales of $2.4 Billion
05:01
Aug29
Alterity Therapeutics released FY2025 earnings on August 28 (EST), actual revenue USD 3.526 M (forecast USD 3.591 M), actual EPS USD -0.7386 (forecast USD -0.82)
03:00
Alterity Therapeutics released FY2025 9 Months Earnings on August 28 (EST), actual revenue USD 2.259 M, actual EPS USD -0.6765
03:00
Alterity Therapeutics released FY2025 Q3 earnings on August 28 (EST), with actual revenue of USD 1.205 M and EPS of USD -0.1252
03:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.25 M, Net Income -1.623 M, EPS -0.1299

Feb28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 499.51 K, Net Income -2.231 M, EPS -0.2612

Aug29
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 706.56 K, Net Income -4.208 M, EPS -0.5262

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
22.710
+236.05%
+15.952
GURE
8.809
+85.84%
+4.069
SMX
258.650
+83.44%
+117.650
WHLR
5.822
+79.69%
+2.560
IRBT
4.210
+38.93%
+1.181
DBRG
12.810
+31.79%
+3.090
PRAX
248.370
+30.74%
+58.400
ALMS
10.775
+29.82%
+2.475
TORO
5.320
+28.81%
+1.200
PAVS
0.0399
+26.67%
+0.008
View More